Jean-Phillippe Metges (Jean-Philippe Metges)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Locally Advanced

Clostridium Difficile

Sentinel Lymph Node

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer reports (Hoboken, N.J.)

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Philip A Philip, Vaibhav Sahai, Nathan Bahary, Amit Mahipal, Anup Kasi Loknath Kumar, Caio Max S Rocha Lima, Angela T Alistar, Paul E Oberstein, Talia Golan, Jean-Phillippe Metges, Jill Lacy, Christos Fountzilas, Charles D Lopez, Michel Ducreux, Pascal Hammel, Mohamed E Salem, David Bajor, Al Bowen Benson, Sanjeev Luther, Timothy Pardee, Eric Van Cutsem
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Vincent Bourbonne, Ulrike Schick, Olivier Pradier, Dimitris Visvikis, Jean-Phillippe Metges, Bogdan Badic
Radiomics Approaches for the Prediction of Pathological Complete Response after Neoadjuvant Treatment in Locally Advanced Rectal Cancer: Ready for Prime Time? Cancers 15 (2) (2023)
Vincent Bourbonne, Ulrike Schick, Olivier Pradier, Dimitris Visvikis, Jean-Phillippe Metges, Bogdan Badic
Radiomics Approaches for the Prediction of Pathological Complete Response after Neoadjuvant Treatment in Locally Advanced Rectal Cancer: Ready for Prime Time? Cancers 15 (2) (2023)
Samuel J Klempner, Keun-Wook Lee, Kohei Shitara, Jean-Phillippe Metges, Sara Lonardi, David H Ilson, Nicola Fazio, Tae-Yong Kim, Li-Yuan Bai, Diarmuid Moran, Jianning Yang, Ahsan Arozullah, Jung Wook Park, Jeffrey J Raizer, Yung-Jue Bang, Manish A Shah
ILUSTRO: Phase 2 Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Vincent Bourbonne, Ulrike Schick, Olivier Pradier, Dimitris Visvikis, Jean-Phillippe Metges, Bogdan Badic
Radiomics Approaches for the Prediction of Pathological Complete Response after Neoadjuvant Treatment in Locally Advanced Rectal Cancer: Ready for Prime Time? Cancers 15 (2) (2023)
Manish A Shah, Kohei Shitara, Florian Lordick, Yung-Jue Bang, Niall C Tebbutt, Jean-Phillippe Metges, Kei Muro, Keun-Wook Lee, Lin Shen, Sergei Tjulandin, John L Hays, Naureen Starling, Rui-Hua Xu, Keren Sturtz, Marilyn Fontaine, Cindy Oh, Emily Brooks, Bo Xu, Wei Li, Chiang J Li, Laura Borodyansky, Eric Van Cutsem
Randomized, double-blind, placebo-controlled phase 3 study of paclitaxel {plus minus} napabucasin in pretreated advanced gastric or gastroesophageal junction adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Manish A Shah, Kohei Shitara, Florian Lordick, Yung-Jue Bang, Niall C Tebbutt, Jean-Phillippe Metges, Kei Muro, Keun-Wook Lee, Lin Shen, Sergei Tjulandin, John L Hays, Naureen Starling, Rui-Hua Xu, Keren Sturtz, Marilyn Fontaine, Cindy Oh, Emily M Brooks, Bo Xu, Wei Li, Chiang J Li, Laura Borodyansky, Eric Van Cutsem
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Vincent Akiki, Xavier Troussard, Jean-Phillippe Metges, Patrick Devos
Global trends in oncology research: A mixed-methods study of publications and clinical trials from 2010 to 2019. Cancer reports (Hoboken, N.J.) (2022)
Jean-Phillippe Metges, Dominique Genet, David Tougeron, Catherine Ligeza, Michel Ducreux, Christophe Borg, Rosine Guimbaud, Jean Marc Phelip, Louis-Marie Dourthe, Stefano Kim
Real-world safety and effectiveness of regorafenib in metastatic colorectal cancer: the French CORRELATE cohort. Future oncology (London, England) 17 (25) (2021)